113 related articles for article (PubMed ID: 9284942)
1. Comparative genomic hybridization analysis of Wilms tumors.
Steenman M; Redeker B; de Meulemeester M; Wiesmeijer K; Voûte PA; Westerveld A; Slater R; Mannens M
Cytogenet Cell Genet; 1997; 77(3-4):296-303. PubMed ID: 9284942
[TBL] [Abstract][Full Text] [Related]
2. Comparative genomic hybridization and its application to Wilms' tumorigenesis.
Getman ME; Houseal TW; Miller GA; Grundy PE; Cowell JK; Landes GM
Cytogenet Cell Genet; 1998; 82(3-4):284-90. PubMed ID: 9858837
[TBL] [Abstract][Full Text] [Related]
3. Screening for submicroscopic chromosomal rearrangements in Wilms tumor using whole-genome microarrays.
Rassekh SR; Chan S; Harvard C; Dix D; Qiao Y; Rajcan-Separovic E
Cancer Genet Cytogenet; 2008 Apr; 182(2):84-94. PubMed ID: 18406869
[TBL] [Abstract][Full Text] [Related]
4. Array CGH profiling of favourable histology Wilms tumours reveals novel gains and losses associated with relapse.
Natrajan R; Williams RD; Hing SN; Mackay A; Reis-Filho JS; Fenwick K; Iravani M; Valgeirsson H; Grigoriadis A; Langford CF; Dovey O; Gregory SG; Weber BL; Ashworth A; Grundy PE; Pritchard-Jones K; Jones C
J Pathol; 2006 Sep; 210(1):49-58. PubMed ID: 16823893
[TBL] [Abstract][Full Text] [Related]
5. Genomic profiling maps loss of heterozygosity and defines the timing and stage dependence of epigenetic and genetic events in Wilms' tumors.
Yuan E; Li CM; Yamashiro DJ; Kandel J; Thaker H; Murty VV; Tycko B
Mol Cancer Res; 2005 Sep; 3(9):493-502. PubMed ID: 16179496
[TBL] [Abstract][Full Text] [Related]
6. Comparative genomic hybridization analysis of hepatoblastomas: additional evidence for a genetic link with Wilms tumor and rhabdomyosarcoma.
Steenman M; Tomlinson G; Westerveld A; Mannens M
Cytogenet Cell Genet; 1999; 86(2):157-61. PubMed ID: 10545709
[TBL] [Abstract][Full Text] [Related]
7. Allelic imbalance at chromosome 1q21 in Wilms tumor.
Law MH; Algar E; Little M
Cancer Genet Cytogenet; 1997 Aug; 97(1):54-9. PubMed ID: 9242218
[TBL] [Abstract][Full Text] [Related]
8. Gain of 1q is associated with adverse outcome in favorable histology Wilms' tumors.
Hing S; Lu YJ; Summersgill B; King-Underwood L; Nicholson J; Grundy P; Grundy R; Gessler M; Shipley J; Pritchard-Jones K
Am J Pathol; 2001 Feb; 158(2):393-8. PubMed ID: 11159177
[TBL] [Abstract][Full Text] [Related]
9. Identification of limited regions of genetic aberrations in patients affected with Wilms' tumor using a tiling-path chromosome 22 array.
Benetkiewicz M; Díaz de Ståhl T; Gördör A; Pfeifer S; Wittmann S; Gessler M; Dumanski JP
Int J Cancer; 2006 Aug; 119(3):571-8. PubMed ID: 16496407
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic correlates of loss of heterozygosity in Wilm's tumor: a preliminary analysis.
Grundy P; Telzerow P; Moksness J; Breslow NE
Med Pediatr Oncol; 1996 Nov; 27(5):429-33. PubMed ID: 8926924
[TBL] [Abstract][Full Text] [Related]
11. Genetic changes of two Wilms tumors with anaplasia and a review of the literature suggesting a marker profile for therapy resistance.
Stock C; Ambros IM; Lion T; Zoubek A; Amann G; Gadner H; Ambros PF
Cancer Genet Cytogenet; 2002 Jun; 135(2):128-38. PubMed ID: 12127397
[TBL] [Abstract][Full Text] [Related]
12. Loss of heterozygosity for chromosomes 16q and 1p in Wilms' tumors predicts an adverse outcome.
Grundy PE; Telzerow PE; Breslow N; Moksness J; Huff V; Paterson MC
Cancer Res; 1994 May; 54(9):2331-3. PubMed ID: 8162576
[TBL] [Abstract][Full Text] [Related]
13. [Comparative genomic hybridization: the profile of chromosomal imbalances in rhabdomyosarcoma].
Li QX; Liu CX; Chun CP; Qi Y; Chang B; Nong WX; Yao ES; Li HA; Li F
Zhonghua Bing Li Xue Za Zhi; 2008 Aug; 37(8):536-41. PubMed ID: 19094465
[TBL] [Abstract][Full Text] [Related]
14. Novel chromosomal abnormalities identified by comparative genomic hybridization in parathyroid adenomas.
Palanisamy N; Imanishi Y; Rao PH; Tahara H; Chaganti RS; Arnold A
J Clin Endocrinol Metab; 1998 May; 83(5):1766-70. PubMed ID: 9589690
[TBL] [Abstract][Full Text] [Related]
15. Chromosomal imbalances revealed in primary rhabdomyo-sarcomas by comparative genomic hybridization.
Li QX; Liu CX; Chun CP; Qi Y; Chang B; Li XX; Chen YZ; Nong WX; Li HA; Li F
Chin Med J (Engl); 2009 Jun; 122(11):1277-82. PubMed ID: 19567137
[TBL] [Abstract][Full Text] [Related]
16. Comparative genomic hybridization of Wilms' tumor.
Rassekh SR; Rajcan-Separovic E
Methods Mol Biol; 2013; 973():249-65. PubMed ID: 23412795
[TBL] [Abstract][Full Text] [Related]
17. Chromosomal imbalance maps of malignant solid tumors: a cytogenetic survey of 3185 neoplasms.
Mertens F; Johansson B; Höglund M; Mitelman F
Cancer Res; 1997 Jul; 57(13):2765-80. PubMed ID: 9205089
[TBL] [Abstract][Full Text] [Related]
18. Complex patterns of chromosome 9 alterations including the p16INK4a locus in Wilms tumours.
Natrajan R; Warren W; Messahel B; Reis-Filho JS; Brundler MA; Dome JS; Grundy PE; Vujanic G; Pritchard-Jones K; Jones C
J Clin Pathol; 2008 Jan; 61(1):95-102. PubMed ID: 17369505
[TBL] [Abstract][Full Text] [Related]
19. Germline and somatic abnormalities of chromosome 7 in Wilms' tumor.
Wilmore HP; White GF; Howell RT; Brown KW
Cancer Genet Cytogenet; 1994 Oct; 77(2):93-8. PubMed ID: 7954327
[TBL] [Abstract][Full Text] [Related]
20. Cytogenetic abnormalities and clinical outcome in Wilms tumor: a study by the U.K. cancer cytogenetics group and the U.K. Children's Cancer Study Group.
Bown N; Cotterill SJ; Roberts P; Griffiths M; Larkins S; Hibbert S; Middleton H; Kelsey A; Tritton D; Mitchell C
Med Pediatr Oncol; 2002 Jan; 38(1):11-21. PubMed ID: 11835232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
